Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Recent Ohio Board of Pharmacy Guidance for MedSpas and IV Therapy Clinics

Client Alert
November 12, 2025

Compliance is vital when operating a MedSpa that holds a Terminal Distributor of Dangerous Drugs (“TDDD”) license or an IV Therapy Clinic. The Ohio Board of Pharmacy (“BOP”) regularly conducts inspections to confirm compliance, and has recently released guidance regarding MedSpas, IV Therapy Clinics, and TDDD licenses. Understanding BOP guidance and implementing appropriate changes can help ensure that your practice is ready for a potential BOP inspection. The following gives insight into the recent BOP guidance.

GLP-1 Guidance:

  • Currently, compounding copies of Tirzepatide and Semaglutide is prohibited.  
  • Retatrutide and Cagrilintide are not permitted to be used in compounding and are not components of any FDA-approved drugs. The BOP states that “all inventory containing Retatrutide or Cagrilintide must be disposed of immediately.”  
  • If a drug is commercially available, it cannot be copied through compounding. There is an exception if the drug is not commercially available, or if the compounded drug “includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product.” The asserted change must be sufficiently documented on the prescription or order.

Compounded Drug Guidance:

  • Prescribers must inspect and approve the compounding process.
  • Using protocols or standing orders for the recommendation, compounding, and administration of IV medication is not authorized.
  • Compounded drug preparation must be appropriately labeled, and should list patient identification information, the name and quantity of each ingredient, the date and time prepared, the beyond use date, and the name and initials of the person who prepared the compounded drug preparation.
  • Compounded drug preparation that is not used by the beyond use date cannot be administered to patients and must be appropriately disposed.
  • Needles used for compounding should never be used for patient administration.

TDDD License Guidance:  

  • In general, practices engaged in drug compounding are required to have a valid and current TDDD license.
  • Before purchasing dangerous drugs, a terminal distributor must verify that a drug wholesaler is licensed to engage in the sale of dangerous drugs in accordance with ORC 4729.52, or that the seller is licensed to engage in the occasional sale or distribution of dangerous drugs at wholesale in accordance with OAC Rule 4729:5-3-09.  
  • Any change in the ownership, business or trade name, category, or address of a TDDD requires a new application, required fee, and license. The new application and required fee must be submitted within thirty days of any change in the ownership, business or trade name, category, or address.
  • Records of dangerous drug administration must be maintained for at least three years from the date of last administration.   
  • Controlled substances must be stored in a securely locked, substantially constructed cabinet or safe. The cabinet or safe cannot be in an area readily accessible to the public, must remain locked and secured when not in use, and must be stored in an area with a physical barrier and suitable locks during non-business hours. The method of accessing the cabinet or safe should prevent unauthorized access.  

To learn more about MedSpa, IV Therapy Clinic, and TDDD license compliance, please contact BMD Member Jeana Singleton at jmsingleton@bmdllc.com or 330-253-2001.

Med SpaHealth LawHealthcareGLP-1
Client Alert

Now in Effect: DOL Final Rule on Classification of Independent Contractors

March 21, 2024Effective March 11, 2024, the U.S. Department of Labor (DOL) has adopted a new standard for the classification of employees versus independent contractors — a much anticipated update since the DOL issued its Final Rule on January 9, 2024, as previously discussed by BMD.  In brief, the Fair Labor Standards Act (FLSA) creates significant protections for workers related to minimum wage, overtime pay, and record-keeping requirements. That said, such protection only exists for employees. This can incentivize entities to classify workers as independent contractors; however, misclassification is risky and can be costly.Client Alert

Florida's Recent Ruling on Arbitration Clauses

March 15, 2024Florida’s recent ruling on arbitration clauses provides a crucial distinction in determining whether such clauses are void as against public policy and providers may have the opportunity to include arbitration clauses in their patient consent forms. On March 6, 2024, Florida’s Fourth District Court of Appeals reversed and remanded Florida’s Fifteenth Circuit Court ruling of Piero Palacios v. Sharnice Lawson. The Court of Appeals ruled that the parties’ arbitration agreement did not contradict the Legislature’s intent of Florida’s Medical Malpractice Act (the “MMA”), but rather reflects the parties’ choice to arbitrate claims entirely outside of the MMA’s framework. Therefore, the Court found that the agreement was not void as against public policy.Client Alert

Corporate Transparency Act Update 3/14/24

March 14, 2024On March 1, 2024, a federal district court in the Northern District of Alabama concluded that the Corporate Transparency Act (“CTA”) exceeded Congressional powers and enjoined the Department of the Treasury from enforcing the CTA against the plaintiffs. National Small Business United v. Yellen, No. 5:22-cv-01448 (N.D. Ala.). On March 11, 2024, the U.S. Department of Justice appealed the district court’s decision to the Eleventh Circuit Court of Appeals.Client Alert

The Ohio State University Launches Its Accelerated Bachelor of Science in Nursing Program

February 27, 2024In response to Ohio’s nursing shortage, The Ohio State University College of Nursing is accepting applications for its new Accelerated Bachelor of Science in Nursing program (aBSN). Created for students with a bachelor’s degree in non-nursing fields, the aBSN allows such students to obtain their nursing degree within 18 months. All aBSN students will participate in high-quality coursework and gain valuable clinical experience. Upon completion of the program, graduates will be eligible to take the State Board, National Council of Licensure Exam for Registered Nursing (NCLEX-RN).Client Alert

Another Transparency Obligation: The FinCEN Beneficial Ownership Information Reporting Requirements

February 26, 2024Many physician practices and healthcare businesses are facing a new set of federal transparency requirements that require action now. The U.S. Department of Treasury Financial Crimes Enforcement Network (“FinCEN”) Beneficial Ownership Information Reporting Requirements (the “Rule”), which was promulgated pursuant to the 2021 bipartisan Corporate Transparency Act, is intended to help curb illegal finance and other impermissible activity in the United States.
Older posts
Newer posts